RE:Let the countdown beginBully88 wrote: Good Morning Stagezeroians,
First off,
Happy new years and I hope everyone had a safe and happy holidays.
I feel very blessed to have made it through 2020 unscathed.
I am very excited for 2021, as I am sure many are.
Covid is still hitting record numbers, deaths and lockdowns and chaos are still amongst us, but as time moves forward, so do we with a light at the end of the tunnel with vaccines and progress, as slow as it is, is still progress.
I am also very excited for Szls for a couple reasons.
1. Q4 2020 Earnings.
2. We are now in the timeframe for the release of Aristotle.
We are all aware that SZLS is making millions of dollars per Q. How long will it last? at this point it is anyones guess...6 months - 1 year seems to be a fair estimate. That being said, we know SZLs is fully funded and has more then enoigh to operate and market Aristotle to their growing list of clients and partners.
I just want to say that as exciting as this development is, I know that it is next to impossible for SZLS to release Aristotle and all of a sudden be making hundreds of millions of dollars and we are all bajillionaires. Would be great, but highly unlikely.
I have an example of a company that is in kind of the same spot that SZLS is in. The company is MEDX Health. MDX.v for refference.
They have a patented technology that scans moles and will tell you with 99+% accurace if you have melenoma. They too are the only ones with this type of technology and are the first and only ones on the market with such tech.
For years they have been building contracts with different countries and market trials. Netherlands, Spain, Brazil, Canada, USA. all are on board and ready to go.
They recently released news that they are now up and running, and are a go in netherlands with their telehealth platform, are in 2 clinics and will be in 40+ clinics by year end. their device sells for $2500 per and every scan they do they charge 10$. All in all a very profitable high recurring revenue SAAS revenue model and are going to be printing money more and more as the days go by.
The reason i bring this example to light is because this news that all the longs have been waiting for their tech to be in the market and fully funded and operating, in hopes will bring their stock to the moon, only brought them up 2 cents from .11 to .13 and then a couple days right back to .11c
Many are disapointed and were expecting a double up but got a quick reminder that what I think matters the most. MONEY
Just because the Tech is ground breaking and first on the market, does not mean the stock will shoot up 10x once its released.
does it deserve more credit and a higher SP? Absolutely. will this company grow and be a 10 bagger? easily.But thats where the Company itself first has to show they can run a profitable company with its product and grow it.
Medx in my opinion is in the same spot SZLS is in.
Once Aristotle is released. I expect the same thing.
What is going to make the most impact on how big of a run we will go on is
1. the type of contracts/partnerships we are begining with. 1 or 2 clincs vs 100+ clinics
2. the pricing of our product and how much revenue we bring in.
3. Our revenue growth model.
I am extremely excited and I have high hopes, as we have been building clients, exposure, partners, and have been planning this for years.
SZLS has an opportunity here to hit a grandslam. no one can argue that fact.
But the best part is even if they hit a single, SZLS will be extremely profitable in a very short period of time.
All in all,
SZLS has stated this is going to happen in Q1 2021.
we now have less then 3 months wait to see if we are hitting singles, doubles, tripples, home runs, or a grand slam. and for that matter if they fail to meet this stated deadline, we strike out.
that being said,
Let the countdown begin.
Cheers all,
Bully
I agree with your logic Bully, however, I believe we won't need actual revenue to point the sp north in a big way. If Aristotle is endorsed by some big medical names and the independent media publishes articles on the breakthrough science it represents - that iin itself would create a furor of investment excitement for the stock. We have all seen numerous companies benefit from this type of phenomenon and appreciate drastically when that investor sentiment turns. I am crossing my fingers hoping that our technology is properly recognized shortly.